Our blogs

​The talent landscape is pretty sparse in biomanufacturing at the moment, albeit for all the right reasons. Interest, investment and productivity are at an all-time high, which means demand has grown rapidly. This is partly down to the pandemic highlighting the importance of getting new products to market (quickly), which has led to important regulatory changes, as well as huge injections of funding. But new technologies also play a big part in this advancement.

​Cell Gene Therapy is the very cutting edge of medical science. The treatments are high impact - awe inspiring, even - this is what promising candidate...